Form EFFECT Adverum Biotechnologies,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 11, 2025 |
| Accession Number: | 0001193125-25-312792 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LBank Exchange Listed GFO (GoodFundOne)
- LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use
- Circles, Greyskies, and HCLTech Collaborate in TM Forum Catalyst Program to Accelerate AI-led Autonomous Network Operations
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
